600 



SUBJECT INDEX 



Mitochondria 



peptide bond synthesis and, 84 



plant cells and, 57 



population, rat liver cells and, 60 



porphyrin synthesis and, 84-85 



rat liver cells and, 38, 39 



rat liver parenchymatous cell and, 31 

 Mitochrome, mitochondria and, 81 

 Molecular shape, ultracentrifugation and, 



257-259 

 Molecular size, ultracentrifugation and, 



257-259 

 Molecular weight, tobacco mosaic virus 



and, 304-307 

 Mouse encephalomyelitis virus, assay of, 



332 

 Multiplicity reactivation, UV inactiva- 



tion and, 377 

 Mumps virus, 12 



adsorption of, 342 



fluorescent antibodies and, 534 



heat inactivation and, 386 



multiplication of, 562 



neutralization of, 539 

 Mutations, reconstituted virus, search 



for, 453-455 

 Mycobacterium tuberculosis, protein syn- 

 thesis and, 136 

 Myxoma virus 



infection initiation and, 346, 348 



local lesion count assay of, 335 

 Myxo viruses, 7-8 



electron microscopy and, 341 



filamentous forms of, 477, 478 



formaldehyde inactivation and, 401 



incomplete forms and, 476, 477 



Negative feedback, enzyme formation 

 inliibition and, 148, 150 



Neodiprion sertifer 



Bombyx mori polyhedra and, 508 

 inclusion body proteins and, 512 



Neodiprion sertifer virus, deoxyribo- 

 nucleic acid of, 515, 516 



Neuraminidase, 151 



bovine submaxillary gland muco- 



protein and, 23 

 influenza virus and, 7-8, 10, 12, 19-20, 



2], 135 

 neuramin-lactose and, 23, 24 



virus particle release and, 24 

 virus penetration and, 24 

 Neuramin-lactose, neuraminidase action 



on, 23, 24 

 Neurospora, 129 



auxotrophy and, 131 

 glutamic dehydrogenase and, 132 

 pantothenate synthesis and, 132 

 tryptophan and, 132-133 

 tryptophan desmolase and, 133 

 tryptophan synthetase and, 134 

 Neurospora crassa, tyrosinase thermo- 

 stability and, 134 

 Neutralization 

 animal viruses 



allantoic cavity and, 544-545 

 chorioallantois and, 540 

 experimental animal test and, 539- 



540 

 inhibition and, 543 

 plaque techniques and, 540-543 

 bacteriophage and, 534-537 

 plant viruses and, 537-538 

 Newcastle disease virus, 12, 411 

 adsorption of, 342 



chemical composition of, 489-490, 497 

 ethylene oxide inactivation and, 412 

 fluorescent antibodies and, 534 

 heat inactivation and, 380 

 hemagglutination and, 344, 346 

 infectivity titration and, 338 

 local lesion count assay of, 335 

 multiplication of, 562 

 neutralization of, 539 

 photodynamic inactivation of, 380 

 plaque-count assay of, 336 

 visible light inactivation of, 380 

 Nicotiana glvtmosa, tobacco mosaic virus 



and, 395-396, 437, 438 

 Nicotiana tabaccum, tobacco mosaic 



virus and, 437 

 Nuclear composition, mineral consti- 

 tuents and, 42^4 

 Nuclear proteins, tests for, 36 

 Nucleic acid, see also Deoxyribonucleic 

 acid and Ribonucleic acid 

 bacteriophage and, 466-467 

 biosynthesis 



animal tissue extracts and, 190-191 

 deoxyribonucleic acid and, 189-191 



